Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03503643 · ClinicalTrials.gov registry record
Hemi-Gland Cryoablation for Prostate Cancer at UCLA
A clinical trial, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- 354
- Enrollment target
NCT03503643 is a clinical trial that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 354 participants.
The verdict
NCT03503643 has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 354 participants
- Enrollment target
Study Summary
This is a prospective data collection of men who are electing to undergo prostate hemi-gland cryoablation. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using hemi-gland cryoablation. UCLA patients undergoing hemi-gland cryoablation are a unique cohort compared to prior research because all patients at UCLA have had a pre-treatment multi-parametric MRI and Ultrasound fusion targeted biopsy; they will be followed in a similar fashion. This results in more precise assessment of a target region of cancer for ablation which may, in turn, result in improved clinical outcomes.
Interventions
- DEVICE Hemigland Cryoablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 2017-09-14 |
| Est. Completion | 2025-08-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03503643
The ClinicalTrials.gov registry entry for NCT03503643 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 354 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hemigland Cryoablation is the first listed.
NCT03503643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03503643 about?
NCT03503643 is a clinical study titled "Hemi-Gland Cryoablation for Prostate Cancer at UCLA". This is a prospective data collection of men who are electing to undergo prostate hemi-gland cryoablation. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using hemi-gland cryoablation. UCLA patients undergoing hemi-gland cryoablation a...
What is the current status of trial NCT03503643?
This trial is currently completed. The enrollment target is 354 participants. The study started on 2017-09-14. Estimated completion is 2025-08-30.
What interventions are being tested in trial NCT03503643?
The interventions under investigation include: Hemigland Cryoablation (DEVICE).
Who is sponsoring clinical trial NCT03503643?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.